⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 30, 2024Open Access

Table 1 from Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer

Daniel R. Principe Mary Pasquinelli Ryan H. Nguyen Hidayatullah G. Munshi Alicia Hulbert Alexandre F. Aissa Frank Weinberg

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Clinical and demographic characteristics of the patient cohort

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Principe et al. (2024) studied this question.

synapsesocial.com/papers/68e5a4ccb6db64358753eefa https://doi.org/10.1158/2767-9764.26878765

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table 1 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
2Figure S2 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
3Figure S6 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
4Figure S3 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
5Figure S5 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024

More related papers

Figure S1 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
Figure S7 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
Figure S8 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024